Natural product therapy for KRAS-mutant lung cancer: Thymoquinone, the most abundant component in Black Cumin – Nigella sativa, decreases the expression of XPO1, increases the level of NFKBIA, inhibits NFKB transcriptional activity and suppresses the progression of KRAS-mutant lung cancer via up regulation of its target gene, 03/October/2016, 10.59 am

Natural product Life-extension therapy: Bergapten (5-methoxypsoralen), a natural psoralen derivative present in many fruits and vegetables, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 2/October/2016, 8.00 am
October 2, 2016
Natural product therapy targeting aberrant Lipid synthesis in Human cancers: Ursolic acid, one of the main components of Tulsi and apple peels, suppresses the expression of the principal enzyme in lipid synthesis, ACLY, inhibits aberrant lipid production in cancer cells and tumor progression via up regulation of its target gene, 3/October/2016, 11.37 am
October 3, 2016
Show all

A recent study from the Department of Cell Biology, University of Texas Southwestern Medical Center, Texas 75390, USA shows that XPO1 can be pharmacologically targeted in KRAS-mutant lung cancer. This study was published in the 28 September 2016 issue of Nature by Prof Michael A.White, Kim, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product therapy for KRAS-mutant lung cancer: Thymoquinone, the most abundant component in Black Cumin – Nigella sativa, decreases the expression of XPO1, increases the level of NFKBIA, inhibits NFKB transcriptional activity and suppresses the progression of KRAS-mutant lung cancer via up regulation of its target gene

Significance:

Given that: (1) 20-30% of people with lung cancer have mutations in k-ras gene; (2) out of 1.82 million people diagnosed with lung cancer in 2012, 1.56 million people died; (3) most of the k-ras mutation-containing lung tumors are not amenable to radiation therapy; (4) there are no effective anti-ras therapy available at present; (5) lung cancer is one of the most frequent cancer in men; (6) lung cancer is more common in developed countries than in developing countries; and (7) the global economic cost spent for lung cancer treatment is enormous, there is an urgent need to find: (a) a newer and effective treatment for K-ras mutated lung cancers; (b) a cheaper alternative to the existing expensive non-specific drugs; and (c) a Natural product-based side-effect-free drug.

Prof. Michael A. White’s research team has recently shown that inhibition of XPO expression in lung cancer inhibits the progression of K-ras mutated lung cancer through down regulation of NFKB transcriptional activity.

On the foundation of this interesting finding, this study suggests a Natural product-based anti-cancer therapy for K-ras mutated human cancers. Thymoquinone, by increasing the expression of its target gene, it may decrease the expression of XPO1.

Thereby, it may: (1) increase the levels of NFKBIA, (2) inhibit NFKB transcriptional activity; and (3) suppress the progression of KRAS-mutant lung cancer. Thus, by treating lung cancer patients with Thymoquinone, one may prevent the progression of Kras-mediated lung cancer.

Together, this study suggests that pharmacological formulations encompassing “Thymoquinone or its analogue”  may be used to inhibit the progression of Kras-mediated lung cancer.

Thymoquinone inhibits the progression of K-ras mutated lung cancers and functions as an anti-cancer agent

Thymoquinone, isolated from  Monarda Fistulosa, inhibits the progression of K-ras mutated lung cancers and functions as an anti-cancer agent

Idea Proposed/Formulated by:

Dr L Boominathan Ph.D.

Web: http://genomediscovery.org or newbioideas.com 

Thymoquinone or its analogue may

Thymoquinone or its analogue may inhibit the progression of K-ras mutated lung cancers via down regulation of XPO1

Citation: Boominathan, Natural product therapy for KRAS-mutant lung cancer: Thymoquinone, the most abundant component in Black Cumin – Nigella sativa, decreases the expression of XPO1, increases the level of NFKBIA, inhibits NFKB transcriptional activity and suppresses the progression of KRAS-mutant lung cancer via up regulation of its target gene, 03/October/2016, 10.59 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation

Undisclosed information: How Thymoquinone decreases the expression of XPO1?

Amount: $300#

satisfaction-guaranted-if-not-refunded

Results guaranteed if not refunded

Comments are closed.